MedTrace Logo

ThermaChoice III Under Local Sedation in the Office Setting

NCT00420264 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2013-08-14

No results posted yet for this study

Summary

Investigational study to determine if an endometrial ablation for heavy uterine bleeding, can be tolerated in the office setting without the use of intravenous medication.

Conditions

  • Heavy Uterine Bleeding

Interventions

DEVICE

Uterine Ablation

Uterine Ablation in the office setting to see if the procedure is tolerated w/o sedation

Sponsors & Collaborators

  • Ethicon, Inc.

    collaborator INDUSTRY

  • Female Pelvic Medicine & Urogynecology Institute of Michigan

    lead OTHER

Principal Investigators

  • Jason B Bennett, MD · Grand Valley Gynecologists, PC

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2008-06-30
Completion
2009-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00420264 on ClinicalTrials.gov